Cardiomatics

Cardiomatics

Private
PolandHealthcare & Life Scienceshttps://cardiomatics.com

Last Round

Seed

Aug 25, 2021

Total Funding Raised

$3.24M

Momentum Score

25 /100

Company Overview

Cardiomatics is a health technology company that has developed a cloud-based, AI-powered platform for electrocardiogram (ECG) analysis. The company's mission is to enhance cardiac diagnostics by providing tools that help healthcare professionals analyze ECG data more efficiently and accurately. Their software is designed to interpret long-term ECG signals from Holter monitors and other ECG patches, reducing analysis time by up to 80%. The platform is a certified medical device (CE/MDR class IIa) and is compliant with GDPR. Cardiomatics aims to bridge the gap between the growing volume of ECG data and the limited number of specialists available to interpret it, thereby improving patient care and workflow for physicians, hospitals, and clinics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS, Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

AI ECG analysisECG analysis softwareHolter analysisarrhythmia detectioncardiology softwareECG AIAI medical devicecloud ECG analysisremote cardiac monitoringECG analysis APIhardware-agnostic ECGCE marked medical deviceusage-based billingelectrocardiogram analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiomatics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cardiomatics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedAug 25, 2021
GrantAug 23, 2021
Pre SeedJul 23, 2019
GrantJul 12, 2019

Key People

Founding team and executive leadership

Rafal Samborski

Chief Executive Officer

Executive Team

Cardiomatics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    Software received CE/MDR certification, classifying it as medical grade.

  • Aug 18, 2025

    Will be present at ESC Congress 2025 in Madrid, Spain.

Cardiomatics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cardiomatics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cardiomatics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range24
Year Founded2017
Last FundingAug 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.